Academic Journal

Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction

التفاصيل البيبلوغرافية
العنوان: Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction
المؤلفون: Martin, Kat, Cofield, Stacey S., Cross, Anne H., Goss, Amy M., Raji, Cyrus A., Rinker, John R., Wu, Gregory F., Blair, Jessica, Fuchs, Anja, Ghezzi, Laura, Green, Kathryn, Pace, Francesca, Pastori, Giovanni, Taylor, Meghan G., Piccio, Laura, Wingo, Brooks C.
المساهمون: K. Martin, S.S. Cofield, A.H. Cro, A.M. Go, C.A. Raji, J.R. Rinker, G.F. Wu, J. Blair, A. Fuch, L. Ghezzi, K. Green, F. Pace, G. Pastori, M.G. Taylor, L. Piccio, B.C. Wingo
بيانات النشر: Elsevier
سنة النشر: 2024
المجموعة: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
مصطلحات موضوعية: Calorie restriction, Glycemic load, Multiple sclerosi, Obesity, Physical function, Settore MED/26 - Neurologia, Settore MEDS-12/A - Neurologia
الوصف: Background: Pilot trials indicate that both a low glycemic load (GL) diet and calorie restriction (CR) can be implemented successfully in people with multiple sclerosis (pMS) and may improve MS symptoms and physical function, but large randomized clinical trials (RCTs) have not yet been conducted. The purpose of this study is to test these interventions alone and in combination to determine their efficacy for improving clinical and patient reported outcomes (PROs) in pMS. Methods: This 32-week, two-arm, RCT at two centers will randomly assign 100 adults with relapsing-remitting or secondary progressive MS to a low GL diet (n = 50) or a standard GL diet (n = 50). Both diet groups will complete two study phases: a eucaloric phase (16 weeks) and a CR phase (16 weeks). Groceries for the study meal plans will be delivered to participants' homes weekly. The primary outcome is physical function, measured by timed 25-ft walk test. Secondary outcomes are pain, fatigue, mood, and anxiety. Discussion: This will be the most rigorous intervention trial to date of a low GL diet and CR in adults with MS, and among the first to assess the impact of intentional weight loss on MS symptoms. Results will provide valuable insight for recommending dietary change, weight loss, or both to adults with MS. These non-drug interventions pose few risks and have potential to yield significant improvements in MS symptoms. Trial registration id: NCT05327322.
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/38821260; info:eu-repo/semantics/altIdentifier/wos/WOS:001256333800001; volume:143; firstpage:1; lastpage:7; numberofpages:7; journal:CONTEMPORARY CLINICAL TRIALS; https://hdl.handle.net/2434/1100909
DOI: 10.1016/j.cct.2024.107584
الاتاحة: https://hdl.handle.net/2434/1100909
https://doi.org/10.1016/j.cct.2024.107584
Rights: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.B65B0BA9
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.cct.2024.107584